Equity
€6,497 ▲ 12.6%
NN Phar has made a profit in every financial year since 2023.
NN Phar
Lifetime
3 annual accounts with figures on one time axispeak €7,703 (2024)
€5,311▼ 31.1%
peak €2,370 (2024)
€727▼ 69.3%
peak €6,497 (2025)
€6,497▲ 12.6%
€10,277▲ 1.8%
Board2 names since 2023
2 directors and 1 other
Documentsfilings and deeds
30-07-20261 day before the deadline
2025micro format
Gross margin from €7,703 to €5,311Result from €2,370 to €727Equity from €5,770 to €6,497Cash from €1,259 to €2,666
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,547 companies had the same profile as NN Phar has now. Each dot stands for 7 companies, two years later.
94.1%
were still trading
3.4%
stopped another way
2.3%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,547 companies, not a prediction for NN Phar. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 04-12-2023
Director, since 04-12-2023
- 100 sharesdeed of 06-12-2023
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1002972080
Incorporation
Founding capital of €1,500, 100 shares · Founder: · Appointments: (director) and (director) · published on 06-12-2023 · Gazette deed
First establishment
Rue du Stampia,St Germain 37, Eghezée
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| NN Phar Eghezée | €16,773 | €5,311 | 38.7% | - |
| Notha Bonheiden | €18,492 | €4,783 | 69.0% | - |
| SERENITY PHARMA Silly | €18,277 | €5,220 | 19.2% | - |
| CAMILLE HUBY Etterbeek | €18,562 | €10,507 | 77.8% | - |
| APHARGA Ferrières | €23,536 | €6,748 | 70.0% | - |
| AB SOCIETY Saint-Ghislain | €31,595 | €7,404 | 80.9% | - |
| VENI Meise | €32,367 | €6,023 | 57.7% | - |
These companies have the same main activity as NN Phar: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €18,300 and €32,400, founded between 2021 and 2025.
Official details
Source: KBO- Status
- Active since 04-12-2023Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 3 others
- Establishment unit
- 2.353.893.7535310 Eghezée, since 04-12-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 16-12-2024
Annual accounts 2025
- €16,773▲ 5.8%
- Filing
- Filed on 30-07-2026, 1 day before the end of the filing period
Insights on NN Phar
NN Phar files the micro format. That format states no turnover. The gross margin rose from €2,741 in 2023 to €5,311 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about NN Phar
- What is the company number of NN Phar?
- The company number of NN Phar is 1002.972.080. The VAT number is the same number with BE in front: BE 1002.972.080.
- Where is NN Phar based?
- The registered office is at Rue du Stampia,St Germain 37, 5310 Eghezée.Company details
- What does NN Phar do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of NN Phar?
- NN Phar is a private limited company (BV).
- When was NN Phar founded?
- NN Phar was founded on 04-12-2023.
- Is NN Phar still active?
- Yes, NN Phar is an active enterprise in the KBO register.
- What is the turnover of NN Phar?
- The turnover in financial year 2025 is ≈ €56,000. This figure is estimated from the gross margin of €5,311 and 118 comparable companies (NACE 477). It probably lies between €20,000 and €120,000. It is a rough estimate.Financials
- Is NN Phar profitable?
- In financial year 2025, NN Phar made a profit of €727.
- Where can I find the annual accounts of NN Phar?
- NN Phar filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of NN Phar due?
- NN Phar must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.